Paliperidone
Brand name: Paliperidone Er
Rank #257 of 500 drugs by total cost
$49.3M
Total Cost
129,516
Total Claims
$49.3M
Total Cost
4,605
Prescribers
$381
Cost per Claim
3,318
Beneficiaries
140,667
30-Day Fills
$11K
Avg Cost/Provider
28
Avg Claims/Provider
About Paliperidone
Paliperidone (sold as Paliperidone Er) was prescribed 129,516 times by 4,605 Medicare Part D providers in 2023, costing the program $49.3M. At $381 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 254 | Amikacin Liposomal/Neb.Accessr (Arikayce) | $50.5M | 3,394 |
| 255 | Diclofenac Epolamine (Licart) | $50.5M | 72,299 |
| 256 | Donepezil Hcl (Donepezil Hcl) | $50.3M | 3,178,215 |
| 257 | Paliperidone (Paliperidone Er) | $49.3M | 129,516 |
| 258 | Sucralfate (Sucralfate) | $48.5M | 689,007 |
| 259 | Diroximel Fumarate (Vumerity) | $48.5M | 5,351 |
| 260 | Cabotegravir/Rilpivirine (Cabenuva) | $48.1M | 7,384 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology